Sun Pharmaceutical Industries Limited (BOM:524715)
India flag India · Delayed Price · Currency is INR
1,664.00
+16.65 (1.01%)
At close: Jun 20, 2025

Revenue by Product

Fiscal year is April - March.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2013 - 2020
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2013 - 2020
India Formulations
169.23B
Log In
Log In
Log In
Log In
Upgrade
India Formulations Growth
13.66%
Log In
Log In
Log In
Log In
Upgrade
US Formulations
162.40B
Log In
Log In
Log In
Log In
Upgrade
US Formulations Growth
5.80%
Log In
Log In
Log In
Log In
Upgrade
Active Pharmaceutical Ingredients (API)
21.29B
Log In
Log In
Log In
Log In
Upgrade
Active Pharmaceutical Ingredients (API) Growth
10.97%
Log In
Log In
Log In
Log In
Upgrade
Others Segment
1.70B
Log In
Log In
Log In
Log In
Upgrade
Others Segment Growth
-36.74%
Log In
Log In
Log In
Log In
Upgrade
Emerging Market
94.16B
Log In
Log In
Log In
Log In
Upgrade
Emerging Market Growth
9.24%
Log In
Log In
Log In
Log In
Upgrade
Rest of the World Formulations
71.63B
Log In
Log In
Log In
Log In
Upgrade
Rest of the World Formulations Growth
6.70%
Log In
Log In
Log In
Log In
Upgrade
Other Operating
5.37B
Log In
Log In
Log In
Log In
Upgrade
Other Operating Growth
-27.25%
Log In
Log In
Log In
Log In
Upgrade

Other

Fiscal year is April - March.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 2012 - 2019
Period Ending
Mar '24 Mar '23 Mar '22 Mar '21 2012 - 2019
Sales per Medical Representative
Log In
Log In
Log In
Log In
Upgrade
Sales per Medical Representative Growth
Log In
Log In
Log In
Log In
Upgrade
Number of Medical Representatives
Log In
Log In
Log In
Log In
Upgrade
Number of Medical Representatives Growth
Log In
Log In
Log In
Log In
Upgrade